tiprankstipranks
Trending News
More News >
Jacobson Pharma Corporation Limited (HK:2633)
:2633
Hong Kong Market

Jacobson Pharma Corporation Limited (2633) Financial Statements

Compare
3 Followers

Jacobson Pharma Corporation Limited Financial Overview

Jacobson Pharma Corporation Limited's market cap is currently HK$3.33B. The company's EPS TTM is HK$0.081; its P/E ratio is 11.55; and it has a dividend yield of 4.00%. Jacobson Pharma Corporation Limited is scheduled to report earnings on June 13, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueHK$ 1.58BHK$ 1.47BHK$ 1.79BHK$ 1.60BHK$ 1.45B
Gross ProfitHK$ 692.94MHK$ 620.48MHK$ 747.17MHK$ 620.52MHK$ 534.15M
Operating IncomeHK$ 414.60MHK$ 333.13MHK$ 319.10MHK$ 222.89MHK$ 185.50M
EBITDAHK$ 558.87MHK$ 489.81MHK$ 462.04MHK$ 415.49MHK$ 377.20M
Net IncomeHK$ 300.83MHK$ 266.97MHK$ 251.04MHK$ 177.67MHK$ 173.71M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 509.05MHK$ 411.94MHK$ 1.04BHK$ 478.65MHK$ 480.35M
Total AssetsHK$ 3.65BHK$ 3.49BHK$ 5.38BHK$ 4.76BHK$ 4.87B
Total DebtHK$ 773.21MHK$ 749.38MHK$ 1.60BHK$ 1.41BHK$ 1.65B
Net DebtHK$ 264.17MHK$ 337.44MHK$ 562.65MHK$ 931.29MHK$ 1.17B
Total LiabilitiesHK$ 1.17BHK$ 1.09BHK$ 2.12BHK$ 1.80BHK$ 2.01B
Stockholders' EquityHK$ 2.45BHK$ 2.37BHK$ 2.74BHK$ 2.49BHK$ 2.39B
Cash Flow
Free Cash FlowHK$ 278.39MHK$ 354.85MHK$ 585.23MHK$ 345.89MHK$ 347.99M
Operating Cash FlowHK$ 526.78MHK$ 484.36MHK$ 648.24MHK$ 409.76MHK$ 411.35M
Investing Cash FlowHK$ -297.76MHK$ 43.34MHK$ -44.09MHK$ -52.75MHK$ -375.40M
Financing Cash FlowHK$ -131.30MHK$ -1.05BHK$ -45.64MHK$ -357.89MHK$ 21.36M
Currency in HKD

Jacobson Pharma Corporation Limited Earnings and Revenue History

Jacobson Pharma Corporation Limited Debt to Assets

Jacobson Pharma Corporation Limited Cash Flow

Jacobson Pharma Corporation Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis